Reliability of the Diagnosis of Cerebral Vasospasm Using Catheter Cerebral Angiography: A Systematic Review and Inter- and Intraobserver Study

References

1. 1.↵
   1. Macdonald RL

   . Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol 2014;10:44–58 doi:10.1038/nrneurol.2013.246 pmid:24323051

   CrossRefPubMed
2. 2.↵
   1. Vergouwen MD,
   2. Ilodigwe D,
   3. Macdonald RL

   . Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke 2011;42:924–29 doi:10.1161/STROKEAHA.110.597914 pmid:21311062

   Abstract/FREE Full Text
3. 3.↵
   1. Andereggen L,
   2. Beck J,
   3. Z’Graggen WJ, et al

   . Feasibility and safety of repeat instant endovascular interventions in patients with refractory cerebral vasospasms. AJNR Am J Neuroradiol 2017;38:561–67 doi:10.3174/ajnr.A5024 pmid:27979797

   Abstract/FREE Full Text
4. 4.↵
   1. Beck J,
   2. Raabe A,
   3. Lanfermann H, et al

   . Effects of balloon angioplasty on perfusion- and diffusion-weighted magnetic resonance imaging results and outcome in patients with cerebral vasospasm. J Neurosurg 2006;105:220–27 doi:10.3171/jns.2006.105.2.220 pmid:17219826

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Turowski B,
   2. Du Mesnil de Rochemont R,
   3. Beck J, et al

   . Assessment of changes in cerebral circulation time due to vasospasm in a specific arterial territory: effect of angioplasty. Neuroradiol 2005;47:134–43 doi:10.1007/s00234-004-1281-4 pmid:15703930

   CrossRefPubMed
6. 6.↵
   1. Muizelaar JP,
   2. Zwienenberg M,
   3. Rudisill NA, et al

   . The prophylactic use of transluminal balloon angioplasty in patients with Fisher grade 3 subarachnoid hemorrhage: a pilot study. J Neurosurg 1999;91:51–58 doi:10.3171/jns.1999.91.1.0051 pmid:10389880

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Zwienenberg-Lee M,
   2. Hartman J,
   3. Rudisill N, et al

   ; Balloon Prophylaxis for Aneurysmal Vasospasm (BPAV) Study Group. Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: results of a phase II multicenter, randomized, clinical trial. Stroke 2008;39:1759–65 doi:10.1161/STROKEAHA.107.502666 pmid:18420953

   Abstract/FREE Full Text
8. 8.↵
   1. Li K,
   2. Barras CD,
   3. Chandra RV, et al

   . A review of the management of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. World Neurosurg 2019;126:513–27 doi:10.1016/j.wneu.2019.03.083 pmid:30898740

   CrossRefPubMed
9. 9.↵
   1. Lindegaard KF,
   2. Nornes H,
   3. Bakke SJ, et al

   . Cerebral vasospasm diagnosis by means of angiography and blood velocity measurements. Acta Neurochir (Wien) 1989;100:12–24 doi:10.1007/BF01405268 pmid:2683600

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Binaghi S,
    2. Colleoni ML,
    3. Maeder P, et al

    . CT angiography and perfusion CT in cerebral vasospasm after subarachnoid hemorrhage. AJNR Am J Neuroradiol 2007;28:750–58 pmid:17416833

    Abstract/FREE Full Text
11. 11.↵
    1. Eskesen V,
    2. Karle A,
    3. Kruse A, et al

    . Observer variability in assessment of angiographic vasospasm after aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 1987;87:54–57 doi:10.1007/BF02076017 pmid:3673683

    CrossRefPubMed
12. 12.↵
    1. Krejza J,
    2. Kochanowicz J,
    3. Mariak Z, et al

    . Middle cerebral artery spasm after subarachnoid hemorrhage: detection with transcranial color-coded duplex US. Radiology 2005;236:621–29 doi:10.1148/radiol.2362031662 pmid:16040918

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Vora YY,
    2. Suarez-Almazor M,
    3. Steinke DE, et al

    . Role of transcranial Doppler monitoring in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 1999;44:1237–47; discussion 1247–48 pmid:10371622

    PubMedWeb of Science
14. 14.↵
    1. Liberati A,
    2. Altman DG,
    3. Tetzlaff J, et al

    . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009;62:e1–34 doi:10.1016/j.jclinepi.2009.06.006 pmid:19631507

    CrossRefPubMed
15. 15.↵
    1. Kottner J,
    2. Audigé L,
    3. Brorson S, et al

    . Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposed. J Clin Epidemiol 2011;64:96–106 doi:10.1016/j.jclinepi.2010.03.002 pmid:21130355

    CrossRefPubMed
16. 16.↵
    1. Sanelli PC,
    2. Ugorec I,
    3. Johnson CE, et al

    . Using quantitative CT perfusion for evaluation of delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol 2011;32:2047–53 doi:10.3174/ajnr.A2693 pmid:21960495

    Abstract/FREE Full Text
17. 17.↵
    1. Letourneau-Guillon L,
    2. Farzin B,
    3. Darsaut TE, et al

    . Reliability of CT angiography in cerebral vasospasm: a systematic review of the literature and an inter- and intraobserver study. AJNR Am J Neuroradiol 2020;41:612–18 doi:10.3174/ajnr.A6462 pmid:32217551

    Abstract/FREE Full Text
18. 18.↵
    1. Takano K,
    2. Hida K,
    3. Iwaasa M, et al

    . Three-dimensional spin-echo-based black-blood MRA in the detection of vasospasm following subarachnoid hemorrhage. J Magn Reson Imaging 2019;49:800–07 doi:10.1002/jmri.26231 pmid:30284331

    CrossRefPubMed
19. 19.↵
    1. Petruk KC,
    2. West M,
    3. Mohr G, et al

    . Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg 1988;68:505–17 doi:10.3171/jns.1988.68.4.0505 pmid:3280746

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Pickard JD,
    2. Murray GD,
    3. Illingworth R, et al

    . Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British Aneurysm Nimodipine Trial. BMJ 1989;298:636–42 doi:10.1136/bmj.298.6674.636 pmid:2496789

    Abstract/FREE Full Text
21. 21.↵
    1. Macdonald RL,
    2. Higashida RT,
    3. Keller E, et al

    . Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol 2011;10:618–25 doi:10.1016/S1474-4422(11)70108-9 pmid:21640651

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Macdonald RL,
    2. Higashida RT,
    3. Keller E, et al

    . Preventing vasospasm improves outcome after aneurysmal subarachnoid hemorrhage: rationale and design of CONSCIOUS-2 and CONSCIOUS-3 trials. Neurocrit Care 2010;13:416–24 doi:10.1007/s12028-010-9433-3 pmid:20838933

    CrossRefPubMed
23. 23.↵
    1. Carlson AP,
    2. Hanggi D,
    3. Wong GK, et al

    ; NEWTON Investigators. Single-dose intraventricular nimodipine microparticles versus oral nimodipine for aneurysmal subarachnoid hemorrhage. Stroke 2020;51:1142–49 doi:10.1161/STROKEAHA.119.027396 pmid:32138631

    CrossRefPubMed